QT Imaging Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by QT Imaging Holdings, Inc. on January 27, 2026. The filing reports a significant corporate event regarding the listing status of the Company's common stock.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate governance event rather than financial performance data.
Material Changes
- Nasdaq Uplisting Approval: On January 27, 2026, the Company received notice from Nasdaq that its Common Stock has been approved for listing on the Nasdaq Capital Market.
- Trading Commencement: Trading on Nasdaq is expected to begin on January 28, 2026, under the ticker symbol "QTI."
Outlook, Risks, and Management Commentary
Management issued a press release announcing the uplisting. The filing includes a comprehensive cautionary note regarding forward-looking statements, highlighting several risks that could cause actual results to differ from expectations:
- Ability to meet continuous Nasdaq listing requirements.
- Commercialization of the QT Imaging Breast Acoustic CT Scanner and extension of product offerings.
- Uncertainty regarding purchase orders, revenue generation, and strategic partnerships.
- An identified material weakness in internal controls over financial reporting and the timeline for remediation.
- Ability to obtain future financing and meet debt obligations.
Investor Verification Checklist
- Verify the commencement of trading on January 28, 2026, under ticker "QTI" on the Nasdaq Capital Market.
- Review the attached press release (Exhibit 99.1) for additional details on the uplisting.
- Monitor future filings for updates on the remediation of the material weakness in internal controls.
- Assess the Company's ability to meet continuous listing standards post-uplisting.